People

Biography
Alison Sexton Ward is an economist with extensive experience on healthcare policy and pharmaceuticals. Her research has focused on economic valuations of various therapies and drug classes, and the economic implications of drug pricing policies. Alison has spent most of her career working with pharmaceutical manufacturers, government agencies, and non-profit health organizations on topics ranging from drug pricing policies, social value of new treatments, and long-term survival prediction. Prior to joining USC, she worked as a senior associate with the Brattle Group where she designed and led economic analysis in support of litigation on health-related issues. Alison joins the Value of Life Science Innovation (VLSI) team led by Karen Van Nuys.
She holds a Ph.D. in Applied Economics from the University of Minnesota, a M.S in Ag and Resource Economics from the University California Davis, and a B.S. in Managerial Economics from the University of California Davis.
Latest Research View All
In The News View All
Medscape
Medicare coverage of obesity drugs could presure other insurers to follow suit, Ward says
Featured Experts: Alison Sexton Ward
KFF Health News
Ward discusses modeling the benefits of anti-obesity medications
Featured Experts: Alison Sexton Ward
STAT
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
Featured Experts: Dana Goldman, Alison Sexton Ward